Inverness Counsel LLC Repligen Corp Transaction History

Inverness Counsel LLC

  • $1.8 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022
SELL
$247.59 - $304.47 $198,072 - $243,576
-800 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$194.77 - $324.21 $155,816 - $259,367
800 New
800 $231,000
Q1 2021

May 04, 2021
SELL
$180.37 - $226.26 $216,444 - $271,512
-1,200 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$148.08 - $206.57 $177,696 - $247,884
1,200 New
1,200 $230,000

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.78B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email